Form 4: BIO-key International CTO Acquires Shares Through Employee Stock Purchase Plan
Insider Transaction Report
BIO-key International's Chief Technology Officer, Mira K. LaCous, acquired 139 shares of common stock at $0.70 per share through the company's Employee Stock Purchase Plan.
Summary
- Mira K. LaCous, Chief Technology Officer of BIO-key International, Inc. (BKYI), acquired 139 shares of common stock.
- The transaction occurred on June 30, 2025.
- The shares were acquired at a price of $0.70 per share.
- This acquisition was made under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan.
- The transaction is exempt under Rule 16b-3(d) and Rule 16b-3(c) of the Securities Exchange Act.
- Following this transaction, Mira K. LaCous beneficially owns 10,758 shares of common stock.
- Holdings do not include options to purchase an additional 87 shares.
Sentiment
Score: 7
Explanation: The acquisition of shares by a key executive, even through an ESPP, generally indicates confidence in the company's future and aligns management's interests with shareholders. While not a large open-market purchase, it's a positive signal.
Positives
- Insider acquisition of shares, indicating management's continued investment in the company.
- Acquisition through an Employee Stock Purchase Plan (ESPP) suggests alignment of employee interests with shareholder value.
Future Outlook
Not applicable. This Form 4 filing details a specific insider transaction and does not provide forward-looking statements or guidance.
Industry Context
This is a routine insider transaction, common across industries for public companies that offer Employee Stock Purchase Plans. It does not provide specific insights into broader industry trends or competitive dynamics.
Related Party Transactions
- The acquisition of shares was conducted under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan, which is a standard related-party transaction mechanism for employee equity participation.
Stakeholder Impact
- Shareholders: The acquisition by a key executive may be viewed positively as it increases insider ownership, potentially signaling confidence in the company's future performance and aligning management's interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of transaction for the acquisition of shares. |
| 07/02/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdKeywords
BIO-key International, BKYI, Form 4, Insider Transaction, Stock Purchase, Employee Stock Purchase Plan, ESPP, Mira K. LaCous, Chief Technology Officer, Equity Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.